Table of Content 1 Scope of the Report 1.1 Market Introduction 1.1 Multiple Sclerosis Introduction 1.2 Research Purposes 1.3 Report Timeline 2 Multiple Sclerosis Market Overview 2.1 World Market Overview 2.1.1 Global Multiple Sclerosis Market Size & Forecast 2017-2028 2.1.2 Multiple Sclerosis Market Size CAGR by Region 2.2 Multiple Sclerosis Market Analysis by Type 2.3 Multiple Sclerosis Market Size Analysis by Type 2.3.1 Global Multiple Sclerosis Market Size Market Share Analysis by Type (2017-2022) 2.3.2 Global Multiple Sclerosis Value and Market Share Analysis by Type (2017-2022) 2.4 Multiple Sclerosis Market Analysis by Applications 2.5 Multiple Sclerosis Market Size Analysis by Application 2.5.1 Global Multiple Sclerosis Market Size Analysis by Application (2017-2022) 2.5.2 Global Multiple Sclerosis Market Share Analysis by Application (2017-2022) 3 Key Players Analysis 3.1 Biogen Inc. 3.1.1 Company Profiles 3.1.2 Multiple Sclerosis Product Introduction 3.1.3 Biogen Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.2 Sanofi 3.2.1 Company Profiles 3.2.2 Multiple Sclerosis Product Introduction 3.2.3 Sanofi Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.3 GlaxoSmithKline plc. 3.3.1 Company Profiles 3.3.2 Multiple Sclerosis Product Introduction 3.3.3 GlaxoSmithKline plc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.4 Celgene Corporation 3.4.1 Company Profiles 3.4.2 Multiple Sclerosis Product Introduction 3.4.3 Celgene Corporation Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.5 Pfizer Inc. 3.5.1 Company Profiles 3.5.2 Multiple Sclerosis Product Introduction 3.5.3 Pfizer Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.6 Novartis AG 3.6.1 Company Profiles 3.6.2 Multiple Sclerosis Product Introduction 3.6.3 Novartis AG Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.7 Teva Pharmaceuticals 3.7.1 Company Profiles 3.7.2 Multiple Sclerosis Product Introduction 3.7.3 Teva Pharmaceuticals Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.8 Synthetic Biologics Inc. 3.8.1 Company Profiles 3.8.2 Multiple Sclerosis Product Introduction 3.8.3 Synthetic Biologics Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.9 Bayer AG 3.9.1 Company Profiles 3.9.2 Multiple Sclerosis Product Introduction 3.9.3 Bayer AG Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.10 Serono Inc. 3.10.1 Company Profiles 3.10.2 Multiple Sclerosis Product Introduction 3.10.3 Serono Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.11 EMD Opexa Therapeutics Inc. 3.11.1 Company Profiles 3.11.2 Multiple Sclerosis Product Introduction 3.11.3 EMD Opexa Therapeutics Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.12 Active Biotech AB, Merck & Co. 3.12.1 Company Profiles 3.12.2 Multiple Sclerosis Product Introduction 3.12.3 Active Biotech AB, Merck & Co. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.13 Actelion Pharmaceuticals Ltd. 3.13.1 Company Profiles 3.13.2 Multiple Sclerosis Product Introduction 3.13.3 Actelion Pharmaceuticals Ltd. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.14 Innate Immunotherapeutics 3.14.1 Company Profiles 3.14.2 Multiple Sclerosis Product Introduction 3.14.3 Innate Immunotherapeutics Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 3.15 InnoBioscience LLC 3.15.1 Company Profiles 3.15.2 Multiple Sclerosis Product Introduction 3.15.3 InnoBioscience LLC Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 4 Global Multiple Sclerosis Historical and Forecast Market Analysis by Types 4.1 Multiple Sclerosis Market Analysis by Types 2017-2022 4.2 Multiple Sclerosis Market Analysis by Types 2023-2028 5 Global Multiple Sclerosis Historical and Forecast Market Analysis by Applications 5.1 Multiple Sclerosis Market Analysis by Applications 2017-2022 5.2 Multiple Sclerosis Market Analysis by Applications 2023-2028 6 North America Multiple Sclerosis Market Analysis 6.1 North America Multiple Sclerosis Market Size (2017-2028) 6.2 Multiple Sclerosis Key Players in North America (2020-2021) 6.3 North America Multiple Sclerosis Market Size by Type (2017-2028) 6.4 North America Multiple Sclerosis Market Size by Application (2017-2028) 7 Europe Multiple Sclerosis Market Analysis 7.1 Europe Multiple Sclerosis Market Size (2017-2028) 7.2 Multiple Sclerosis Key Players in Europe (2020-2021) 7.3 Europe Multiple Sclerosis Market Size by Type (2017-2028) 7.4 Europe Multiple Sclerosis Market Size by Application (2017-2028) 8 China Multiple Sclerosis Market Analysis 8.1 China Multiple Sclerosis Market Size (2017-2028) 8.2 Multiple Sclerosis Key Players in China (2020-2021) 8.3 China Multiple Sclerosis Market Size by Type (2017-2028) 8.4 China Multiple Sclerosis Market Size by Application (2017-2028) 9 Japan Multiple Sclerosis Market Analysis 9.1 Japan Multiple Sclerosis Market Size (2017-2028) 9.2 Multiple Sclerosis Key Players in Japan (2020-2021) 9.3 Japan Multiple Sclerosis Market Size by Type (2017-2028) 9.4 Japan Multiple Sclerosis Market Size by Application (2017-2028) 10 Southeast Asia Multiple Sclerosis Market Analysis 10.1 Southeast Asia Multiple Sclerosis Market Size (2017-2028) 10.2 Multiple Sclerosis Key Players in Southeast Asia (2020-2021) 10.3 Southeast Asia Multiple Sclerosis Market Size by Type (2017-2028) 10.4 Southeast Asia Multiple Sclerosis Market Size by Application (2017-2028) 11 India Multiple Sclerosis Market Analysis 11.1 India Multiple Sclerosis Market Size (2017-2028) 11.2 Multiple Sclerosis Key Players in India (2020-2021) 11.3 India Multiple Sclerosis Market Size by Type (2017-2028) 11.4 India Multiple Sclerosis Market Size by Application (2017-2028) 12 Multiple Sclerosis Market Dynamics 12.1 Market Drivers 12.2 Market Restraints 12.3 Opportunity 12.4 Market Trends 13 Research Findings and Conclusion 14 Methodology and Data Source 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.2.3 Legal Disclaimer

List of Tables and Figures Figure Multiple Sclerosis Picture Table Product Definition of Multiple Sclerosis Figure Multiple Sclerosis Report Years Considered Figure Global Multiple Sclerosis Market Size & Forecast 2017-2028 Table Global Multiple Sclerosis Market Size Growth Rate by Region (2023-2028) Table Global Multiple Sclerosis Market Size by Regions 2017-2022 Table Types of Multiple Sclerosis Table Global Multiple Sclerosis Market Size Market Share Analysis by Type (2017-2022) Table Global Multiple Sclerosis Value Analysis by Type (2017-2022) Table Application of Multiple Sclerosis Table Global Multiple Sclerosis Market Size Analysis by Application (2017-2022) Table Global Multiple Sclerosis Market Share Analysis by Application (2017-2022) Figure Top 3 Market Share of Multiple Sclerosis Companies in 2021 Figure Top 6 Market Share of Multiple Sclerosis Companies in 2021 Table Major Players Value ($) Share (2017-2022) Table Biogen Inc. Company Profiles Table Multiple Sclerosis Product Introduction Table Biogen Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Biogen Inc. Value ($) Market Share 2017-2022 Table Sanofi Company Profiles Table Multiple Sclerosis Product Introduction Table Sanofi Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Sanofi Value ($) Market Share 2017-2022 Table GlaxoSmithKline plc. Company Profiles Table Multiple Sclerosis Product Introduction Table GlaxoSmithKline plc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure GlaxoSmithKline plc. Value ($) Market Share 2017-2022 Table Celgene Corporation Company Profiles Table Multiple Sclerosis Product Introduction Table Celgene Corporation Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Celgene Corporation Value ($) Market Share 2017-2022 Table Pfizer Inc. Company Profiles Table Multiple Sclerosis Product Introduction Table Pfizer Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Pfizer Inc. Value ($) Market Share 2017-2022 Table Novartis AG Company Profiles Table Multiple Sclerosis Product Introduction Table Novartis AG Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Novartis AG Value ($) Market Share 2017-2022 Table Teva Pharmaceuticals Company Profiles Table Multiple Sclerosis Product Introduction Table Teva Pharmaceuticals Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Teva Pharmaceuticals Value ($) Market Share 2017-2022 Table Synthetic Biologics Inc. Company Profiles Table Multiple Sclerosis Product Introduction Table Synthetic Biologics Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Synthetic Biologics Inc. Value ($) Market Share 2017-2022 Table Bayer AG Company Profiles Table Multiple Sclerosis Product Introduction Table Bayer AG Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Bayer AG Value ($) Market Share 2017-2022 Table Serono Inc. Company Profiles Table Multiple Sclerosis Product Introduction Table Serono Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Serono Inc. Value ($) Market Share 2017-2022 Table EMD Opexa Therapeutics Inc. Company Profiles Table Multiple Sclerosis Product Introduction Table EMD Opexa Therapeutics Inc. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure EMD Opexa Therapeutics Inc. Value ($) Market Share 2017-2022 Table Active Biotech AB, Merck & Co. Company Profiles Table Multiple Sclerosis Product Introduction Table Active Biotech AB, Merck & Co. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Active Biotech AB, Merck & Co. Value ($) Market Share 2017-2022 Table Actelion Pharmaceuticals Ltd. Company Profiles Table Multiple Sclerosis Product Introduction Table Actelion Pharmaceuticals Ltd. Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Actelion Pharmaceuticals Ltd. Value ($) Market Share 2017-2022 Table Innate Immunotherapeutics Company Profiles Table Multiple Sclerosis Product Introduction Table Innate Immunotherapeutics Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure Innate Immunotherapeutics Value ($) Market Share 2017-2022 Table InnoBioscience LLC Company Profiles Table Multiple Sclerosis Product Introduction Table InnoBioscience LLC Multiple Sclerosis Value, Gross, Gross Margin 2017-2022 Figure InnoBioscience LLC Value ($) Market Share 2017-2022 Table Global Multiple Sclerosis Revenue Market Size Analysis by Types 2017-2022 Table Global Multiple Sclerosis Revenue Market Share Analysis by Types 2017-2022 Table Global Multiple Sclerosis Revenue Market Size Analysis by Types 2023-2028 Table Global Multiple Sclerosis Revenue Market Share Analysis by Types 2023-2028 Table Global Multiple Sclerosis Revenue Market Size Analysis by Applications 2017-2022 Table Global Multiple Sclerosis Revenue Market Share Analysis by Applications 2017-2022 Table Global Multiple Sclerosis Revenue Market Size Analysis by Applications 2023-2028 Table Global Multiple Sclerosis Revenue Market Share Analysis by Applications 2023-2028 Figure North America Multiple Sclerosis Market Size (2017-2028) Table Multiple Sclerosis Key Players in North America (2020-2021) Table North America Multiple Sclerosis Market Size by Types (2017-2028) Table North America Multiple Sclerosis Market Size Market Share by Applications (2017-2028) Figure Europe Multiple Sclerosis Market Size (2017-2028) Table Multiple Sclerosis Key Players in Europe (2020-2021) Table Europe Multiple Sclerosis Market Size by Types (2017-2028) Table Europe Multiple Sclerosis Market Size Market Share by Applications (2017-2028) Figure China Multiple Sclerosis Market Size (2017-2028) Table Multiple Sclerosis Key Players in China (2020-2021) Table China Multiple Sclerosis Market Size by Types (2017-2028) Table China Multiple Sclerosis Market Size Market Share by Applications (2017-2028) Figure Japan Multiple Sclerosis Market Size (2017-2028) Table Multiple Sclerosis Key Players in Japan (2020-2021) Table Japan Multiple Sclerosis Market Size by Types (2017-2028) Table Japan Multiple Sclerosis Market Size Market Share by Applications (2017-2028) Figure Southeast Asia Multiple Sclerosis Market Size (2017-2028) Table Multiple Sclerosis Key Players in Southeast Asia (2020-2021) Table Southeast Asia Multiple Sclerosis Market Size by Types (2017-2028) Table Southeast Asia Multiple Sclerosis Market Size Market Share by Applications (2017-2028) Figure India Multiple Sclerosis Market Size (2017-2028) Table Multiple Sclerosis Key Players in India (2020-2021) Table India Multiple Sclerosis Market Size by Types (2017-2028) Table India Multiple Sclerosis Market Size Market Share by Applications (2017-2028) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources